Research Article
Assessing non‐inferiority of a new treatment in a three‐arm clinical trial including a placebo
Abstract
In non‐inferiority trials, where non‐inferiority of a new experimental drug compared to an active control has to be shown, it may be advisable to use an additional placebo group for internal validation if ethically justifiable. The focus of this paper is on such designs. Assuming normality and homogeneity of variances we will derive a statistical test procedure which turns out to be equivalent to the assessment based on Fieller's confidence interval. Based on the power function of this test, sample size calculations are carried out to achieve a given power. Additionally, the optimal allocation of the total sample size is derived. As an alternative to this parametric procedure, the bootstrap percentile interval is discussed and finally compared with Fieller's confidence interval in a study on mildly asthmatic patients. Copyright © 2003 John Wiley & Sons, Ltd.
Citing Literature
Number of times cited according to CrossRef: 95
- Qian Wen, Ning Li, Xueling Wang, Hao Li, Fengwei Tian, Weiwei Chen, Yanyan Lu, Zhishun Liu, Effect of electroacupuncture versus solifenacin for moderate and severe overactive bladder: a multi-centre, randomized controlled trial study protocol, BMC Complementary Medicine and Therapies, 10.1186/s12906-020-03018-y, 20, 1, (2020).
- Yuanjie Sun, Yan Liu, Tongsheng Su, Jianhua Sun, Ying Wu, Zhishun Liu, Electroacupuncture versus solifenacin for women with urgency-predominant mixed urinary incontinence: a protocol for a three-armed non-inferiority randomized controlled trial, BMC Complementary Medicine and Therapies, 10.1186/s12906-019-2784-1, 20, 1, (2020).
- Niansheng Tang, Bin Yu, Simultaneous confidence interval for assessing non‐inferiority with assay sensitivity in a three‐arm trial with binary endpoints, Pharmaceutical Statistics, 10.1002/pst.2010, 19, 5, (518-531), (2020).
- Samiran Ghosh, Erina Paul, Shrabanti Chowdhury, Ram C. Tiwari, New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes, Biostatistics, 10.1093/biostatistics/kxaa014, (2020).
- Gosuke Homma, Takashi Daimon, Sample Size Calculation for “Gold-Standard” Noninferiority Trials With Fixed Margins and Negative Binomial Endpoints, Statistics in Biopharmaceutical Research, 10.1080/19466315.2020.1766551, (1-13), (2020).
- Milind A. Phadnis, Matthew S. Mayo, Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time, Journal of Applied Statistics, 10.1080/02664763.2020.1753026, (1-24), (2020).
- Yongqiang Tang, Notes on Exact Power Calculations for t Tests and Analysis of Covariance , Statistics in Biopharmaceutical Research, 10.1080/19466315.2019.1707110, (1-3), (2020).
- Peng Wang, Siqi Xu, Yi‐Xin Wang, Baolin Wu, Wing Kam Fung, Guimin Gao, Zhijiang Liang, Nianjun Liu, Penalized Fieller's confidence interval for the ratio of bivariate normal means, Biometrics, 10.1111/biom.13363, 0, 0, (2020).
- Gosuke Homma, Takashi Daimon, Sequential parallel comparison design for “gold standard” noninferiority trials with a prespecified margin, Biometrical Journal, 10.1002/bimj.201800394, 61, 6, (1493-1506), (2019).
- Sylvia Schmidt, Werner Brannath, Simultaneous confidence intervals for ratios with application to the gold standard design with more than one experimental treatment, Statistics in Medicine, 10.1002/sim.8365, 38, 28, (5350-5360), (2019).
- Shrabanti Chowdhury, Ram C. Tiwari, Samiran Ghosh, Bayesian Approach for Assessing Non-Inferiority in Three-Arm Trials for Risk Ratio and Odds Ratio, Statistics in Biopharmaceutical Research, 10.1080/19466315.2018.1554504, 11, 1, (34-43), (2019).
- Michael J. Adjabui, Nathaniel K. Howard, Mathias Akamba, Biostatistical Assessment of Mutagenicity Studies: A Stepwise Confidence Procedure, Journal of Probability and Statistics, 10.1155/2019/3249097, 2019, (1-8), (2019).
- Eisuke Hida, Toshiro Tango, Design and analysis of a 3‐arm noninferiority trial with a prespecified margin for the hazard ratio, Pharmaceutical Statistics, 10.1002/pst.1875, 17, 5, (489-503), (2018).
- Santu Ghosh, Ram C. Tiwari, Samiran Ghosh, Bayesian approach for assessing noninferiority in a three‐arm trial with binary endpoint, Pharmaceutical Statistics, 10.1002/pst.1851, 17, 4, (342-357), (2018).
- Shrabanti Chowdhury, Ram C. Tiwari, Samiran Ghosh, Non-inferiority testing for risk ratio, odds ratio and number needed to treat in three-arm trial, Computational Statistics & Data Analysis, 10.1016/j.csda.2018.08.018, (2018).
- Tobias Mütze, Tim Friede, Blinded sample size re‐estimation in three‐arm trials with ‘gold standard’ design, Statistics in Medicine, 10.1002/sim.7356, 36, 23, (3636-3653), (2017).
- Santu Ghosh, Arpita Chatterjee, Samiran Ghosh, Non-inferiority test based on transformations for non-normal distributions, Computational Statistics & Data Analysis, 10.1016/j.csda.2016.10.004, 113, (73-87), (2017).
- Andre R. Brunoni, Adriano H. Moffa, Bernardo Sampaio-Junior, Lucas Borrione, Marina L. Moreno, Raquel A. Fernandes, Beatriz P. Veronezi, Barbara S. Nogueira, Luana V.M. Aparicio, Lais B. Razza, Renan Chamorro, Luara C. Tort, Renerio Fraguas, Paulo A. Lotufo, Wagner F. Gattaz, Felipe Fregni, Isabela M. Benseñor, Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression, New England Journal of Medicine, 10.1056/NEJMoa1612999, 376, 26, (2523-2533), (2017).
- Chi-Rong Li, Tsai-Yu Lin, Generalized simultaneous confidence regions for regression coefficients and their ratios, Journal of Statistical Computation and Simulation, 10.1080/00949655.2017.1299735, 87, 10, (1940-1950), (2017).
- Ying Wu, Yiqun Li, Yan Hou, Kang Li, Xiaohua Zhou, Study duration for three-arm non-inferiority survival trials designed for accrual by cohorts, Statistical Methods in Medical Research, 10.1177/0962280216633908, 27, 2, (507-520), (2016).
- Tobias Mütze, Frank Konietschke, Axel Munk, Tim Friede, A studentized permutation test for three‐arm trials in the ‘gold standard’ design, Statistics in Medicine, 10.1002/sim.7176, 36, 6, (883-898), (2016).
- Toshimitsu Ochiai, Toshimitsu Hamasaki, Scott R. Evans, Koko Asakura, Yuko Ohno, Group-sequential three-arm noninferiority clinical trial designs, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2016.1148710, 27, 1, (1-24), (2016).
- Yu-Wei Chang, Yi Tsong, Zhigen Zhao, Sample size determination for a three-arm equivalence trial of Poisson and negative binomial responses, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2016.1269787, 27, 2, (239-256), (2016).
- Ming Zhou, Sudeep Kundu, Some practical considerations in three‐arm non‐inferiority trial design, Pharmaceutical Statistics, 10.1002/pst.1779, 15, 6, (550-559), (2016).
- Kallappa M. Koti, New Generalized p -Value Approach for Noninferiority Analysis , Statistics in Biopharmaceutical Research, 10.1080/19466315.2015.1093958, 8, 1, (35-39), (2016).
- Gernot Wassmer, Werner Brannath, Gernot Wassmer, Werner Brannath, Applications, Group Sequential and Confirmatory Adaptive Designs in Clinical Trials, 10.1007/978-3-319-32562-0_5, (101-130), (2016).
- Toshimitsu Hamasaki, Koko Asakura, Scott R. Evans, Toshimitsu Ochiai, Toshimitsu Hamasaki, Koko Asakura, Scott R. Evans, Toshimitsu Ochiai, Group-Sequential Three-Arm Non-inferiority Clinical Trials, Group-Sequential Clinical Trials with Multiple Co-Objectives, 10.1007/978-4-431-55900-9_6, (81-95), (2016).
- Hezhi Lu, Hua Jin, Weixiong Zeng, A more efficient three-arm non-inferiority test based on pooled estimators of the homogeneous variance, Statistical Methods in Medical Research, 10.1177/0962280216681036, (096228021668103), (2016).
- Huang Li-Ching, Wen Miin-Jye, Cheung Siu Hung, Kwong Koon Shing, Noninferiority studies with multiple reference treatments, Statistical Methods in Medical Research, 10.1177/0962280215576017, 26, 3, (1295-1307), (2015).
- Tobias Mütze, Axel Munk, Tim Friede, Design and analysis of three‐arm trials with negative binomially distributed endpoints, Statistics in Medicine, 10.1002/sim.6738, 35, 4, (505-521), (2015).
- Samiran Ghosh, Santu Ghosh, Ram C. Tiwari, Bayesian approach for assessing non‐inferiority in a three‐arm trial with pre‐specified margin, Statistics in Medicine, 10.1002/sim.6746, 35, 5, (695-708), (2015).
- Georg Ferber, Ekkehard Glimm, Translational Science Biostatistics, Principles of Translational Science in Medicine, 10.1016/B978-0-12-800687-0.00029-3, (267-280), (2015).
- André Russowsky Brunoni, Bernardo Sampaio-Junior, Adriano Henrique Moffa, Lucas Borrione, Barbara Schwair Nogueira, Luana Vanessa Marotti Aparício, Beatriz Veronezi, Marina Moreno, Raquel Albano Fernandes, Diego Tavares, Priscila Vilela Silveira Bueno, Ole Seibt, Marom Bikson, Renerio Fraguas, Isabela Martins Benseñor, The Escitalopram versus Electric Current Therapy for Treating Depression Clinical Study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial, Sao Paulo Medical Journal, 10.1590/1516-3180.2014.00351712, 133, 3, (252-263), (2015).
- Frank Schaarschmidt, Gemechis D. Djira, Simultaneous Confidence Intervals for Ratios of Fixed Effect Parameters in Linear Mixed Models, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2013.849741, 45, 5, (1704-1717), (2014).
- Li-Ching Huang, Miin-Jye Wen, Siu Hung Cheung, Noninferiority Studies with Multiple New Treatments and Heterogeneous Variances, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2014.920346, 25, 5, (958-971), (2014).
- Ying Wu, Liang Zhao, Yan Hou, Kang Li, Xiaohua Zhou, Correcting for non‐compliance in randomized non‐inferiority trials with active and placebo control using structural models, Statistics in Medicine, 10.1002/sim.6392, 34, 6, (950-965), (2014).
- Nian-Sheng Tang, Bin Yu, Man-Lai Tang, Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints, BMC Medical Research Methodology, 10.1186/1471-2288-14-134, 14, 1, (2014).
- Yu-Wei Chang, Yi Tsong, Xiaoyu Dong, Zhigen Zhao, Sample Size Determination for a Three-Arm Equivalence Trial of Normally Distributed Responses, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2014.948552, 24, 6, (1190-1202), (2014).
- Sujung Park, Dongjae Kim, Nonparametric Method for a Non-inferiority Test using Confidence Interval, Korean Journal of Applied Statistics, 10.5351/KJAS.2014.27.5.833, 27, 5, (833-842), (2014).
- Patrick Schlömer, Werner Brannath, Group sequential designs for three‐arm ‘gold standard’ non‐inferiority trials with fixed margin, Statistics in Medicine, 10.1002/sim.5950, 32, 28, (4875-4889), (2013).
- Karola Kombrink, Axel Munk, Tim Friede, Design and semiparametric analysis of non‐inferiority trials with active and placebo control for censored time‐to‐event data, Statistics in Medicine, 10.1002/sim.5769, 32, 18, (3055-3066), (2013).
- Yi Tsong, Joanne Zhang, Active-Controlled Clinical Trials, Modern Clinical Trial Analysis, 10.1007/978-1-4614-4322-3, (167-182), (2013).
- Eisuke Hida, Toshiro Tango, Three-Arm Noninferiority Trials with a Prespecified Margin for Inference of the Difference in the Proportions of Binary Endpoints, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2013.789893, 23, 4, (774-789), (2013).
- Joseph Millum, Christine Grady, The ethics of placebo-controlled trials: Methodological justifications, Contemporary Clinical Trials, 10.1016/j.cct.2013.09.003, 36, 2, (510-514), (2013).
- Ling Deng, Gang Chen, A More Powerful Test Based on Ratio Distribution for Retention Noninferiority Hypothesis, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2011.616968, 23, 2, (346-360), (2013).
- Shein‐Chung Chow, Jun Wang, Laszlo Endrenyi, Peter A. Lachenbruch, Scientific considerations for assessing biosimilar products, Statistics in Medicine, 10.1002/sim.5571, 32, 3, (370-381), (2012).
- Seung‐Ho Kang, Shein‐Chung Chow, Statistical assessment of biosimilarity based on relative distance between follow‐on biologics, Statistics in Medicine, 10.1002/sim.5582, 32, 3, (382-392), (2012).
- Koon Shing Kwong, Siu Hung Cheung, Anthony J. Hayter, Miin‐Jye Wen, Extension of three‐arm non‐inferiority studies to trials with multiple new treatments, Statistics in Medicine, 10.1002/sim.5467, 31, 24, (2833-2843), (2012).
- Mario Hasler, Multiple comparisons to both a negative and a positive control, Pharmaceutical Statistics, 10.1002/pst.503, 11, 1, (74-81), (2012).
- Kathrin Stucke, Meinhard Kieser, A general approach for sample size calculation for the three‐arm ‘gold standard’ non‐inferiority design, Statistics in Medicine, 10.1002/sim.5461, 31, 28, (3579-3596), (2012).
- Mark A Gamalo, Saman Muthukumarana, Pulak Ghosh, Ram C Tiwari, A generalized p -value approach for assessing noninferiority in a three-arm trial , Statistical Methods in Medical Research, 10.1177/0962280210395739, 22, 3, (261-277), (2011).
- Ivan Chan, Three-Arm Non-Inferiority Trials, Design and Analysis of Non-Inferiority Trials, 10.1201/b11039-7, (149-165), (2011).
- Eisuke Hida, Toshiro Tango, Response to Joachim Röhmel and Iris Pigeot, Statistics in Medicine, 10.1002/sim.4313, 30, 26, (3165-3165), (2011).
- Pulak Ghosh, Farouk Nathoo,, Mithat Gönen, Ram C. Tiwari, Assessing noninferiority in a three‐arm trial using the Bayesian approach, Statistics in Medicine, 10.1002/sim.4244, 30, 15, (1795-1808), (2011).
- Mark Chang, Mark Chang, Noninferiority Trial Design, Modern Issues and Methods in Biostatistics, 10.1007/978-1-4419-9842-2_3, (59-86), (2011).
- Eisuke Hida, Toshiro Tango, On the three‐arm non‐inferiority trial including a placebo with a prespecified margin, Statistics in Medicine, 10.1002/sim.4099, 30, 3, (224-231), (2010).
- Mohammad F. Huque, Mohamed Alosh, Satya D. Dubey, Rafia Bhore, Shein-Chung Chow, P -Values, Evidence, and Multiplicity Considerations for Controlled Clinical Trials , Encyclopedia of Biopharmaceutical Statistics, 10.3109/9781439822463, (949-961), (2010).
- Joachim Röhmel, Iris Pigeot, A Comparison of Multiple Testing Procedures for the Gold Standard Non-Inferiority Trial, Journal of Biopharmaceutical Statistics, 10.1080/10543401003618942, 20, 5, (911-926), (2010).
- Amy H. Kaji, Roger J. Lewis, Are We Looking for Superiority, Equivalence, or Noninferiority? Asking the Right Question and Answering It Correctly, Annals of Emergency Medicine, 10.1016/j.annemergmed.2010.01.024, 55, 5, (408-411), (2010).
- Gang Li, Shan Gao, A group sequential type design for three‐arm non‐inferiority trials with binary endpoints, Biometrical Journal, 10.1002/bimj.200900188, 52, 4, (504-518), (2010).
- Ullrich Munzel, Nonparametric non‐inferiority analyses in the three‐arm design with active control and placebo, Statistics in Medicine, 10.1002/sim.3727, 28, 29, (3643-3656), (2009).
- Johannes Fleckenstein, Sybille Kramer, Philipp Hoffrogge, Sarah Thoma, Philip M Lang, Lukas Lehmeyer, Gabriel M Schober, Florian Pfab, Johannes Ring, Peter Weisenseel, Klaus J Schotten, Ulrich Mansmann, Dominik Irnich, Acupuncture in acute herpes zoster pain therapy (ACUZoster) – design and protocol of a randomised controlled trial, BMC Complementary and Alternative Medicine, 10.1186/1472-6882-9-31, 9, 1, (2009).
- Fadoua Balabdaoui, Matthias Mielke, Axel Munk, The likelihood ratio test for non-standard hypotheses near the boundary of the null – with application to the assessment of non-inferiority, Statistics & Decisions, 10.1524/stnd.2009.1022, 27, 1, (2009).
- Holger Dette, Matthias Trampisch, Ludwig A. Hothorn, Robust Designs in Noninferiority Three-Arm Clinical Trials With Presence of Heteroscedasticity, Statistics in Biopharmaceutical Research, 10.1198/sbr.2009.0021, 1, 3, (268-278), (2009).
- Axel Munk, Matthias Mielke, Gudrun Freitag, Guido Skipka, Testing noninferiority in three‐armed clinical trials based on likelihood ratio statistics, Canadian Journal of Statistics, 10.1002/cjs.5550350306, 35, 3, (413-431), (2009).
- undefined &NA;, Meaningful interpretation of clinical trials requires careful consideration of their findings, Drugs & Therapy Perspectives, 10.2165/00042310-200824030-00008, 24, 3, (23-26), (2008).
- Ji-Sun Lee, Dong-Jae Kim, Non-Inferiority Test in a Two-Arm Trial and a Three-Arm Trial Including a Placebo, Korean Journal of Applied Statistics, 10.5351/KJAS.2008.21.6.947, 21, 6, (947-957), (2008).
- Martin Schumacher, Guido Schwarzer, Martin Schumacher, Gabi Schulgen/Kristiansen, Die Beurteilung der Gleichwertigkeit von Behandlungen, Methodik klinischer Studien, 10.1007/978-3-540-85136-3, (113-127), (2008).
- Matthias Mielke, A. Munk, A. Schacht, The assessment of non‐inferiority in a gold standard design with censored, exponentially distributed endpoints, Statistics in Medicine, 10.1002/sim.3348, 27, 25, (5093-5110), (2008).
- Mario Hasler, Richardus Vonk, Ludwig A. Hothorn, Assessing non‐inferiority of a new treatment in a three‐arm trial in the presence of heteroscedasticity, Statistics in Medicine, 10.1002/sim.3052, 27, 4, (490-503), (2007).
- Gary G. Koch, Comments on ‘Current issues in non‐inferiority trials’ by Thomas R. Fleming, Statistics in Medicine, DOI: 10.1002/sim.2855, Statistics in Medicine, 10.1002/sim.2923, 27, 3, (333-342), (2007).
- Michael Hollifield, Nityamo Sinclair-Lian, Teddy D. Warner, Richard Hammerschlag, Acupuncture for Posttraumatic Stress Disorder, The Journal of Nervous and Mental Disease, 10.1097/NMD.0b013e31803044f8, 195, 6, (504-513), (2007).
- L.A. Hothorn, How to deal with multiple treatment or dose groups in randomized clinical trials?, Fundamental & Clinical Pharmacology, 10.1111/j.1472-8206.2007.00469.x, 21, 2, (137-154), (2007).
- Yi Tsong, The Utility of Active-Controlled Noninferiority/Equivalence Trials in Drug Development, International Journal of Pharmaceutical Medicine, 10.2165/00124363-200721030-00005, 21, 3, (225-233), (2007).
- Philipp Fueglistaler, Michel Adamina, Ulrich Guller, Non-Inferiority Trials in Surgical Oncology, Annals of Surgical Oncology, 10.1245/s10434-006-9295-2, 14, 5, (1532-1539), (2007).
- Yi Tsong, Wen-Jen Chen, Noninferiority Testing Beyond Simple Two-Sample Comparison∗, Journal of Biopharmaceutical Statistics, 10.1080/10543400601177368, 17, 2, (289-308), (2007).
- Yi Tsong, Joanne Zhang, Simultaneous Test for Superiority and Noninferiority Hypotheses in Active-Controlled Clinical Trials∗, Journal of Biopharmaceutical Statistics, 10.1080/10543400601177434, 17, 2, (247-257), (2007).
- Kallappa M. Koti, Use of the Fieller–Hinkley Distribution of the Ratio of Random Variables in Testing for Noninferiority, Journal of Biopharmaceutical Statistics, 10.1080/10543400601177335, 17, 2, (215-228), (2007).
- Tim Friede, Charles Mitchell, Günther Müller‐Velten, Blinded Sample Size Reestimation in Non‐Inferiority Trials with Binary Endpoints, Biometrical Journal, 10.1002/bimj.200610373, 49, 6, (903-916), (2007).
- An introductory note to the CHMP guidelines: choice of the non‐inferiority margin and data monitoring committees by David Brown, Peter Volkers and Simon Day, Statistics in Medicine 2006; 25:1623–1627, Statistics in Medicine, 10.1002/sim.2665, 26, 1, (230-233), (2006).
- Meinhard Kieser, Tim Friede, Planning and analysis of three‐arm non‐inferiority trials with binary endpoints, Statistics in Medicine, 10.1002/sim.2543, 26, 2, (253-273), (2006).
- Yong-Cheng Wang, Gang Chen, George Y.H. Chi, A Ratio Test in Active Control Non-Inferiority Trials with a Time-to-Event Endpoint, Journal of Biopharmaceutical Statistics, 10.1080/10543400500508754, 16, 2, (151-164), (2006).
- Todd A. Schwartz, Jonathan S. Denne, A two‐stage sample size recalculation procedure for placebo‐ and active‐controlled non‐inferiority trials, Statistics in Medicine, 10.1002/sim.2651, 25, 19, (3396-3406), (2006).
- Kousuke Okamoto, Makiko Higashi, Masahiko Yokota, Rika Nishikiori, Mie Osaki, Teruo Yasunaga, Tatsuya Takagi, New computer-intensive procedures for testing null hypotheses comparing two parameters approximately, Chemometrics and Intelligent Laboratory Systems, 10.1016/j.chemolab.2005.04.014, 82, 1-2, (66-74), (2006).
- Nobuyuki Koyama, Discussion about Points to Consider on Switching between Superiority and Non-inferiority & Guideline on the Choice of Non-inferiority Margin, Japanese Journal of Biometrics, 10.5691/jjb.27.S105, 27, Special_Issue, (S105-S115), (2006).
- Gemechis Dilba, Frank Bretz, Ludwig A. Hothorn, Volker Guiard, Power and sample size computations in simultaneous tests for non‐inferiority based on relative margins, Statistics in Medicine, 10.1002/sim.2359, 25, 7, (1131-1147), (2005).
- Joachim Röhmel, Discussion on “Establishing Efficacy of a New Experimental Treatment in the ‘Gold Standard’ Design”, Biometrical Journal, 10.1002/bimj.200510184, 47, 6, (790-791), (2005).
- Dieter Hauschke, Iris Pigeot, Rejoinder to “Establishing Efficacy of a New Experimental Treatment in the ‘Gold Standard’ Design”, Biometrical Journal, 10.1002/bimj.200510179, 47, 6, (797-798), (2005).
- Joachim Röhmel, On Confidence Bounds for the Ratio of Net Differences in the “Gold Standard” Design with Reference, Experimental, and Placebo Treatment, Biometrical Journal, 10.1002/bimj.200510178, 47, 6, (799-806), (2005).
- Dieter Hauschke, Iris Pigeot, Establishing Efficacy of a New Experimental Treatment in the ‘Gold Standard’ Design, Biometrical Journal, 10.1002/bimj.200510169, 47, 6, (782-786), (2005).
- Yi Tsong, Juan (Joanne) Zhang, Testing Superiority and Non‐Inferiority Hypotheses in Active Controlled Clinical Trials, Biometrical Journal, 10.1002/bimj.200410089, 47, 1, (62-74), (2005).
- Dieter Hauschke, Renate Slacik‐Erben, Sabrina Hensen, Ronny Kaufmann, Biostatistical Assessment of Mutagenicity Studies by Including the Positive Control, Biometrical Journal, 10.1002/bimj.200410082, 47, 1, (82-87), (2005).
- Man-Lai Tang, Nian-Sheng Tang, Tests of Noninferiority via Rate Difference for Three-Arm Clinical Trials with Placebo, Journal of Biopharmaceutical Statistics, 10.1081/BIP-120037184, 14, 2, (337-347), (2004).
- Thomas R. Weihrauch, Placebo treatment is effective differently in different diseases — but is it also harmless? A brief synopsis, Science and Engineering Ethics, 10.1007/s11948-004-0072-y, 10, 1, (151-155), (2004).
- Armin Koch, Joachim Röhmel, Hypothesis Testing in the “Gold Standard” Design for Proving the Efficacy of an Experimental Treatment Relative to Placebo and a Reference, Journal of Biopharmaceutical Statistics, 10.1081/BIP-120037182, 14, 2, (315-325), (2004).
